Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 261

1.

Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study.

Pecori C, Giannini M, Portaccio E, Ghezzi A, Hakiki B, Pastò L, Razzolini L, Sturchio A, De Giglio L, Pozzilli C, Paolicelli D, Trojano M, Marrosu MG, Patti F, Mancardi GL, Solaro C, Totaro R, Tola MR, De Luca G, Lugaresi A, Moiola L, Martinelli V, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.

BMC Neurol. 2014 May 26;14:114. doi: 10.1186/1471-2377-14-114.

PMID:
24884599
[PubMed - in process]
Free PMC Article
2.

Defining the clinical course of multiple sclerosis: The 2013 revisions.

Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof F, Bebo B Jr, Calabresi PA, Clanet M, Comi G, Fox RJ, Freedman MS, Goodman AD, Inglese M, Kappos L, Kieseier BC, Lincoln JA, Lubetzki C, Miller AE, Montalban X, O'Connor PW, Petkau J, Pozzilli C, Rudick RA, Sormani MP, Stüve O, Waubant E, Polman CH.

Neurology. 2014 Jul 15;83(3):278-286. Epub 2014 May 28. Review.

PMID:
24871874
[PubMed - as supplied by publisher]
3.

Oral dalfampridine improves standing balance detected at static posturography in multiple sclerosis.

Prosperini L, Giannì C, Fortuna D, Marchetti MR, Pozzilli C.

Mult Scler Int. 2014;2014:802307. doi: 10.1155/2014/802307. Epub 2014 Mar 27.

PMID:
24800078
[PubMed]
Free PMC Article
4.

Sustained disability improvement is associated with T1 lesion volume shrinkage in natalizumab-treated patients with multiple sclerosis.

Prosperini L, De Angelis F, De Angelis R, Fanelli F, Pozzilli C.

J Neurol Neurosurg Psychiatry. 2014 Apr 30. doi: 10.1136/jnnp-2014-307786. [Epub ahead of print] No abstract available.

PMID:
24790213
[PubMed - as supplied by publisher]
5.

Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial.

Laroni A, Brogi D, Morra VB, Guidi L, Pozzilli C, Comi G, Lugaresi A, Turrini R, Raimondi D, Uccelli A, Mancardi GL; EAP Investigators.

BMC Neurol. 2014 Apr 1;14:65. doi: 10.1186/1471-2377-14-65.

PMID:
24690227
[PubMed - in process]
Free PMC Article
6.

Oral ponesimod in relapsing-remitting multiple sclerosis: a randomised phase II trial.

Olsson T, Boster A, Fernández O, Freedman MS, Pozzilli C, Bach D, Berkani O, Mueller MS, Sidorenko T, Radue EW, Melanson M.

J Neurol Neurosurg Psychiatry. 2014 Apr 8. doi: 10.1136/jnnp-2013-307282. [Epub ahead of print]

PMID:
24659797
[PubMed - as supplied by publisher]
Free Article
7.

Erratum to: Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group.

Bertolotto A, Capobianco M, Amato MP, Capello E, Capra R, Centonze D, Di Ioia M, Gallo A, Grimaldi L, Imberti L, Lugaresi A, Mancinelli C, Marrosu MG, Moiola L, Montanari E, Romano S, Musu L, Paolicelli D, Patti F, Pozzilli C, Rossi S, Salvetti M, Tedeschi G, Tola MR, Trojano M, Zaffaroni M, Malucchi S.

Neurol Sci. 2014 Feb 2. [Epub ahead of print] No abstract available.

PMID:
24487700
[PubMed - as supplied by publisher]
8.

Multiple sclerosis: altered thalamic resting-state functional connectivity and its effect on cognitive function.

Tona F, Petsas N, Sbardella E, Prosperini L, Carmellini M, Pozzilli C, Pantano P.

Radiology. 2014 Jun;271(3):814-21. doi: 10.1148/radiol.14131688. Epub 2014 Jan 24.

PMID:
24484065
[PubMed - indexed for MEDLINE]
9.

From high- to low-frequency administered interferon-beta for multiple sclerosis: a multicenter study.

Prosperini L, Mancinelli CR, Pozzilli C, Grasso MG, Clemenzi A, Collorone S, Pontecorvo S, Francia A, Villani V, Koudriavtseva T, Buttari F, Centonze D, Di Battista G, Frisullo G, Galgani S, Gasperini C.

Eur Neurol. 2014;71(5-6):233-41. doi: 10.1159/000356786. Epub 2014 Jan 25.

PMID:
24480868
[PubMed - in process]
10.

Overview of MS spasticity.

Pozzilli C.

Eur Neurol. 2014;71 Suppl 1:1-3. doi: 10.1159/000357739. Epub 2014 Jan 22. No abstract available.

PMID:
24457845
[PubMed - in process]
11.

The MoSt Project--more steps in multiple sclerosis: a Delphi method consensus initiative for the evaluation of mobility management of MS patients in Italy.

Capra R, Battaglia MA, Gaudioso A, Lopes L, Paolicelli D, Paoloni M, Pozzilli C, Santilli V, Solaro C, Trojano M.

J Neurol. 2014 Mar;261(3):526-32. doi: 10.1007/s00415-013-7230-6. Epub 2014 Jan 22.

PMID:
24449060
[PubMed - in process]
12.

Interferon-beta-1a treatment has a positive effect on quality of life of relapsing-remitting multiple sclerosis: results from a longitudinal study.

Patti F, Pappalardo A, Montanari E, Pesci I, Barletta V, Pozzilli C.

J Neurol Sci. 2014 Feb 15;337(1-2):180-5. doi: 10.1016/j.jns.2013.12.006. Epub 2013 Dec 26.

PMID:
24433926
[PubMed - in process]
13.

Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs.

Portaccio E, Ghezzi A, Hakiki B, Sturchio A, Martinelli V, Moiola L, Patti F, Mancardi GL, Solaro C, Tola MR, Pozzilli C, De Giglio L, Totaro R, Lugaresi A, De Luca G, Paolicelli D, Marrosu MG, Comi G, Trojano M, Amato MP; MS Study Group of the Italian Neurological Society.

J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):845-50. doi: 10.1136/jnnp-2013-306054. Epub 2014 Jan 8.

PMID:
24403285
[PubMed - in process]
14.

Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group.

Bertolotto A, Capobianco M, Amato MP, Capello E, Capra R, Centonze D, Di Ioia M, Gallo A, Grimaldi L, Imberti L, Lugaresi A, Mancinelli C, Marrosu MG, Moiola L, Montanari E, Romano S, Musu L, Paolicelli D, Patti F, Pozzilli C, Rossi S, Salvetti M, Tedeschi G, Tola MR, Troiano M, Zaffaroni M, Malucchi S.

Neurol Sci. 2014 Feb;35(2):307-16. doi: 10.1007/s10072-013-1616-1. Epub 2013 Dec 29.

PMID:
24374787
[PubMed - in process]
15.

Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS.

Ristori G, Romano S, Cannoni S, Visconti A, Tinelli E, Mendozzi L, Cecconi P, Lanzillo R, Quarantelli M, Buttinelli C, Gasperini C, Frontoni M, Coarelli G, Caputo D, Bresciamorra V, Vanacore N, Pozzilli C, Salvetti M.

Neurology. 2014 Jan 7;82(1):41-8. doi: 10.1212/01.wnl.0000438216.93319.ab. Epub 2013 Dec 4.

PMID:
24306002
[PubMed - indexed for MEDLINE]
16.

Advances in the management of multiple sclerosis spasticity: experiences from recent studies and everyday clinical practice.

Pozzilli C.

Expert Rev Neurother. 2013 Dec;13(12 Suppl):49-54. doi: 10.1586/14737175.2013.865877. Review.

PMID:
24289844
[PubMed - indexed for MEDLINE]
17.

Mood and coping in clinically isolated syndrome and multiple sclerosis.

Bianchi V, De Giglio L, Prosperini L, Mancinelli C, De Angelis F, Barletta V, Pozzilli C.

Acta Neurol Scand. 2014 Jun;129(6):374-81. doi: 10.1111/ane.12194. Epub 2013 Oct 30.

PMID:
24172013
[PubMed - in process]
18.

Interferon beta failure predicted by EMA criteria or isolated MRI activity in multiple sclerosis.

Prosperini L, Mancinelli CR, De Giglio L, De Angelis F, Barletta V, Pozzilli C.

Mult Scler. 2014 Apr;20(5):566-76. doi: 10.1177/1352458513502399. Epub 2013 Sep 2.

PMID:
23999607
[PubMed - in process]
19.

Guidelines from The Italian Neurological and Neuroradiological Societies for the use of magnetic resonance imaging in daily life clinical practice of multiple sclerosis patients.

Filippi M, Rocca MA, Bastianello S, Comi G, Gallo P, Gallucci M, Ghezzi A, Marrosu MG, Minonzio G, Pantano P, Pozzilli C, Tedeschi G, Trojano M, Falini A, De Stefano N; Neuroimaging and MS Study Groups of the Italian Society of Neurology; Functional Neuroradiology Section of the Italian Association of Neuroradiology.

Neurol Sci. 2013 Dec;34(12):2085-93. doi: 10.1007/s10072-013-1485-7. Epub 2013 Jul 5. Review.

PMID:
23828372
[PubMed - indexed for MEDLINE]
20.

Evidence of impaired brain activity balance after passive sensorimotor stimulation in multiple sclerosis.

Petsas N, Tinelli E, Lenzi D, Tomassini V, Sbardella E, Tona F, Raz E, Nucciarelli V, Pozzilli C, Pantano P.

PLoS One. 2013 Jun 14;8(6):e65315. doi: 10.1371/journal.pone.0065315. Print 2013.

PMID:
23799005
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk